Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Free Cash Flow Generation Index
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Free Cash Flow Generation Index of 0.27x as of September 2025. Free cash flow of CN¥108.45 Million represents 0% of operating cash flow (CN¥400.70 Million). Read 002294 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Salubris Pharmaceuticals Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Explore Shenzhen Salubris Pharmaceuticals Co Ltd (002294) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Shenzhen Salubris Pharmaceuticals Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥561.45 Million | CN¥1.19 Billion | CN¥624.81 Million | ▲ +144.4% |
| 2023 | 0.19x | CN¥168.44 Million | CN¥869.79 Million | CN¥671.00 Million | ▼ -49.4% |
| 2022 | 0.38x | CN¥371.84 Million | CN¥970.80 Million | CN¥598.96 Million | ▼ -35.4% |
| 2021 | 0.59x | CN¥702.48 Million | CN¥1.18 Billion | CN¥482.50 Million | ▲ +11.3% |
| 2020 | 0.53x | CN¥731.86 Million | CN¥1.37 Billion | CN¥642.47 Million | ▼ -23.5% |
| 2019 | 0.70x | CN¥1.05 Billion | CN¥1.51 Billion | CN¥457.19 Million | ▼ -7.3% |
| 2018 | 0.75x | CN¥1.01 Billion | CN¥1.34 Billion | CN¥332.87 Million | ▼ -2.7% |
| 2017 | 0.77x | CN¥1.13 Billion | CN¥1.46 Billion | CN¥331.67 Million | ▼ -6.8% |
| 2016 | 0.83x | CN¥1.19 Billion | CN¥1.43 Billion | CN¥245.06 Million | ▲ +6.7% |
| 2015 | 0.78x | CN¥820.46 Million | CN¥1.06 Billion | CN¥235.57 Million | ▼ -2.4% |
| 2014 | 0.80x | CN¥781.59 Million | CN¥982.25 Million | CN¥200.65 Million | ▲ +120.4% |
| 2013 | 0.36x | CN¥241.32 Million | CN¥668.52 Million | CN¥427.20 Million | ▼ -19.8% |
| 2012 | 0.45x | CN¥234.46 Million | CN¥521.21 Million | CN¥286.75 Million | ▲ +521.2% |
| 2011 | 0.07x | CN¥19.72 Million | CN¥272.32 Million | CN¥252.60 Million | ▲ +136.7% |
| 2010 | -0.20x | CN¥-36.83 Million | CN¥186.65 Million | CN¥223.48 Million | ▼ -1799.6% |
| 2009 | -0.01x | CN¥-1.39 Million | CN¥134.28 Million | CN¥135.68 Million | ▼ -104.9% |
| 2008 | 0.21x | CN¥16.41 Million | CN¥77.89 Million | CN¥61.48 Million | ▼ -71.5% |
| 2007 | 0.74x | CN¥39.05 Million | CN¥52.75 Million | CN¥13.71 Million | ▲ +286.5% |
| 2006 | 0.19x | CN¥2.30 Million | CN¥12.00 Million | CN¥9.71 Million | — |